TrialIndian journal of pharmacology2024

Efficacy, safety, and cost-effectiveness of biosimilars of bevacizumab in näive patients with diabetic macular edema.

Shalini Virani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.